Ranolazine STADA

Medicinal product

(Invented) name

Ranolazine STADA

Active substance (s)

Ranolazinas

Strength

375 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C01EB18, Ranolazine

Marketing authorisation holder

STADA Arzneimittel AG, Vokietija

Date of authorisation

2022-06-23

Date of renewal

Documents

4978_4979_4980 Pakuotės lapelis 2022 06 23t.docx

4978_4979_4980 Ranolazine STADA 2022 06 23t.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/5495/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Ranolazinas	375 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108893	94999	1094999	lizdinė plokštelė	N30		Receptinis	LT/1/22/4978/001	Netiekiama	-	-	No	-	-
108894	95000	1095000	lizdinė plokštelė	N60		Receptinis	LT/1/22/4978/002	Tiekiama	-	-	No	-	-	Download
108895	95001	1095001	lizdinė plokštelė	N100		Receptinis	LT/1/22/4978/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-06-23	Registruotas